274 related articles for article (PubMed ID: 16194069)
1. High-throughput screening for enzyme inhibitors using frontal affinity chromatography with liquid chromatography and mass spectrometry.
Ng ES; Yang F; Kameyama A; Palcic MM; Hindsgaul O; Schriemer DC
Anal Chem; 2005 Oct; 77(19):6125-33. PubMed ID: 16194069
[TBL] [Abstract][Full Text] [Related]
2. Two-dimensional turbulent flow chromatography coupled on-line to liquid chromatography-mass spectrometry for solution-based ligand screening against multiple proteins.
Zhou JL; An JJ; Li P; Li HJ; Jiang Y; Cheng JF
J Chromatogr A; 2009 Mar; 1216(12):2394-403. PubMed ID: 19203758
[TBL] [Abstract][Full Text] [Related]
3. Frontal affinity chromatography coupled to mass spectrometry for screening mixtures of enzyme inhibitors.
Zhang B; Palcic MM; Schriemer DC; Alvarez-Manilla G; Pierce M; Hindsgaul O
Anal Biochem; 2001 Dec; 299(2):173-82. PubMed ID: 11730340
[TBL] [Abstract][Full Text] [Related]
4. Frontal affinity chromatography with MS detection (FAC-MS) in drug discovery.
Slon-Usakiewicz JJ; Ng W; Dai JR; Pasternak A; Redden PR
Drug Discov Today; 2005 Mar; 10(6):409-16. PubMed ID: 15808820
[TBL] [Abstract][Full Text] [Related]
5. Capillary-scale frontal affinity chromatography/MALDI tandem mass spectrometry using protein-doped monolithic silica columns.
Kovarik P; Hodgson RJ; Covey T; Brook MA; Brennan JD
Anal Chem; 2005 May; 77(10):3340-50. PubMed ID: 15889927
[TBL] [Abstract][Full Text] [Related]
6. Automated multiple ligand screening by frontal affinity chromatography-mass spectrometry (FAC-MS).
Ng W; Dai JR; Slon-Usakiewicz JJ; Redden PR; Pasternak A; Reid N
J Biomol Screen; 2007 Mar; 12(2):167-74. PubMed ID: 17218664
[TBL] [Abstract][Full Text] [Related]
7. Drug screening of pharmaceutical discovery compounds by micro-size exclusion chromatography/mass spectrometry.
Wabnitz PA; Loo JA
Rapid Commun Mass Spectrom; 2002; 16(2):85-91. PubMed ID: 11754252
[TBL] [Abstract][Full Text] [Related]
8. High-throughput cytochrome p450 inhibition assays by ultrafast gradient liquid chromatography with tandem mass spectrometry using monolithic columns.
Peng SX; Barbone AG; Ritchie DM
Rapid Commun Mass Spectrom; 2003; 17(6):509-18. PubMed ID: 12621611
[TBL] [Abstract][Full Text] [Related]
9. Frontal affinity chromatography with MS detection of EphB2 tyrosine kinase receptor. 1. Comparison with conventional ELISA.
Slon-Usakiewicz JJ; Ng W; Foster JE; Dai JR; Deretey E; Toledo-Sherman L; Redden PR; Pasternak A; Reid N
J Med Chem; 2004 Oct; 47(21):5094-100. PubMed ID: 15456253
[TBL] [Abstract][Full Text] [Related]
10. Screening for galectin-3 inhibitors from synthetic lacto-N-biose libraries using microscale affinity chromatography coupled to mass spectrometry.
Fort S; Kim HS; Hindsgaul O
J Org Chem; 2006 Sep; 71(19):7146-54. PubMed ID: 16958507
[TBL] [Abstract][Full Text] [Related]
11. Development of an ultrafiltration-liquid chromatography/mass spectrometry (UF-LC/MS) based ligand-binding assay and an LC/MS based functional assay for Mycobacterium tuberculosis shikimate kinase.
Mulabagal V; Calderón AI
Anal Chem; 2010 May; 82(9):3616-21. PubMed ID: 20394394
[TBL] [Abstract][Full Text] [Related]
12. Frontal affinity chromatography with MS detection of EphB2 tyrosine kinase receptor. 2. Identification of small-molecule inhibitors via coupling with virtual screening.
Toledo-Sherman L; Deretey E; Slon-Usakiewicz JJ; Ng W; Dai JR; Foster JE; Redden PR; Uger MD; Liao LC; Pasternak A; Reid N
J Med Chem; 2005 May; 48(9):3221-30. PubMed ID: 15857128
[TBL] [Abstract][Full Text] [Related]
13. Frontal affinity chromatography-mass spectrometry.
Ng ES; Chan NW; Lewis DF; Hindsgaul O; Schriemer DC
Nat Protoc; 2007; 2(8):1907-17. PubMed ID: 17703202
[TBL] [Abstract][Full Text] [Related]
14. Target-based drug discovery: the emerging success of frontal affinity chromatography coupled to mass spectrometry.
Calleri E; Temporini C; Caccialanza G; Massolini G
ChemMedChem; 2009 Jun; 4(6):905-16. PubMed ID: 19378293
[TBL] [Abstract][Full Text] [Related]
15. Mass spectrometric techniques for label-free high-throughput screening in drug discovery.
Roddy TP; Horvath CR; Stout SJ; Kenney KL; Ho PI; Zhang JH; Vickers C; Kaushik V; Hubbard B; Wang YK
Anal Chem; 2007 Nov; 79(21):8207-13. PubMed ID: 17902631
[TBL] [Abstract][Full Text] [Related]
16. Determination of in vitro permeability of drug candidates through a caco-2 cell monolayer by liquid chromatography/tandem mass spectrometry.
Wang Z; Hop CE; Leung KH; Pang J
J Mass Spectrom; 2000 Jan; 35(1):71-6. PubMed ID: 10633236
[TBL] [Abstract][Full Text] [Related]
17. Streamlined system for purifying and quantifying a diverse library of compounds and the effect of compound concentration measurements on the accurate interpretation of biological assay results.
Popa-Burke IG; Issakova O; Arroway JD; Bernasconi P; Chen M; Coudurier L; Galasinski S; Jadhav AP; Janzen WP; Lagasca D; Liu D; Lewis RS; Mohney RP; Sepetov N; Sparkman DA; Hodge CN
Anal Chem; 2004 Dec; 76(24):7278-87. PubMed ID: 15595870
[TBL] [Abstract][Full Text] [Related]
18. Application of frontal affinity chromatography with mass spectrometry (FAC-MS) for stereospecific ligand-macromolecule interaction, detection and screening.
Slon-Usakiewicz JJ; Redden P
Methods Mol Biol; 2009; 572():219-30. PubMed ID: 20694695
[TBL] [Abstract][Full Text] [Related]
19. Assay development and screening of human DGAT1 inhibitors with an LC/MS-based assay: application of mass spectrometry for large-scale primary screening.
Zhang JH; Roddy TP; Ho PI; Horvath CR; Vickers C; Stout S; Hubbard B; Wang YK; Hill WA; Bojanic D
J Biomol Screen; 2010 Jul; 15(6):695-702. PubMed ID: 20484097
[TBL] [Abstract][Full Text] [Related]
20. The development of a staggered parallel separation liquid chromatography/tandem mass spectrometry system with on-line extraction for high-throughout screening of drug candidates in biological fluids.
Wu JT
Rapid Commun Mass Spectrom; 2001; 15(2):73-81. PubMed ID: 11180533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
